Danish sugar and ingredients company Danisco is planning to relocate much of its biotech research operations to the US in order to produce genetically modified products.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The company has already conducted research into GM products but under EU law it cannot produce the products. Danisco hopes that it will be easier to get the necessary permission in the US to produce its new hexose oxidase enzyme.